First Ever Gene-Editing Therapy for Hyperlipidemia Achieves Key Milestone CorrectSequence Therapeutics has made a historic innovation by administering the first gene-editing therapy aimed at treating hyperlipidemia. Learn more about this groundbreaking advancement.

First Ever Gene-Editing Therapy for Hyperlipidemia Achieves Key Milestone #China #Shanghai #CorrectSequence_Therapeutics #CS-121 #APOC3